Why the study?
Do Norovirus virus-like particle vaccines prevent acute gastroenteritis in humans?
Population
Humans susceptible to norovirus infection
Design
Review
Authors
Loading...
Supports NoV VLP vaccine development; leaves open confirmation of gastroenteritis prevention in larger trials.
Do Norovirus virus-like particle vaccines prevent acute gastroenteritis in humans?
Norovirus VLP vaccines represent a promising strategy to induce protective antibodies and prevent homologous viral infection in humans.
Richardson et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: